medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2014, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (3)

“Super Giant” Basal Cell Carcinoma Presenting as a Chronic Ulcer: Case report and review literature

López ZJB, Álvarez AN, Riera LA, Briseño RG, Villanueva QDG

Language: Spanish
References: 30
Page: 191-196
PDF size: 215.19 Kb.


ABSTRACT

The most common skin cancer, basal cell carcinoma is a slow-growing malignant tumor, with minimal metastatic risk. And while giant basal cell carcinoma is a rare and aggressive form of bad prognosis, it represents only 1% of all cases. However, various authors have recently proposed the term “super giant basal cell carcinoma” to describe lesions exceeding 20 cm. in diameter.
This is the case report presenting with a 9 year-old right inguinal ulcer, ultimately diagnosed as “super giant basal cell carcinoma”.


REFERENCES

  1. Secretaría de Salud. “Perfil epidemiológico de los tumores malignos en México. Sistema Nacional de Vigilancia Epidemiológica”. México, D.F; 2011; 10-200 disponible en: http://www.epidemiologia.salud.gob. mx/doctos/infoepid/publicaciones/2011/monografias/P_EPI_DE_ LOS_TUMORES_MALIGNOS_M%C3%A9xico.pdf

  2. Soyer HP, Rigel DS, Wurm. “Actinic keratosis, basal cell carcinoma and squamous cell carcinoma”. En: Bolognia J, Jorizzo JL, Schaffer JV, Dermatology, vol 2, 3ª ed, Londres, United Kingdom: Elsevier-Saunders; 2012, pp. 1784-1793.

  3. Zocalli G, Pajand R, Papa G, Orsini G, Lomartire N, Giuliani M. “Giant basal cell carcinoma of the skin: literature review and personal experience”. J Eur Acad Dermatol Venereol. 2012; 26: 942-952.

  4. Archontaki M, Stavrianos SD, Korkolis DP, Arnogiannaki N, Vassiliadis V, Liapakis IE. “Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature”. Anticancer Res. 2009; 29: 2655-2663.

  5. Randle HW, Roenigk RK, Brodland DG. “Giant basal cell carcinoma (T3). Who is at risk?” Cancer 1993; 72: 1624-1630.

  6. Betti R, Inselvini F, Moneghini L, Crosti C. “Giant basal cell carcinoma: report of four cases and considerations”. J Dermatol 1997; 24: 317-321.

  7. De Bree E, Laliotis A, Manios A, Tsiftsis DD, Melissas J. “Super giant basal cell carcinoma of the abdominal wall: still possible in the 21st century”. Int J Dermatol 2010; 49: 806-809.

  8. Fresini A, Rossiello L, Severino BU, Del Prete M, Satriano RA. “Giant basal cell carcinoma”. Skinmed 2007; 6: 204-205.

  9. Madan V, West CA, Murphy JV, Lear JT. “Sequential treatment of giant basal cell carcinomas”. J Plast Reconstr Aesthet Surg 2009; 62: 368-372.

  10. Calista D. “Photodynamic therapy for the treatment of a giant superficial basal cell carcinoma”. Photodermatol Photoimmunol Photomed. 2009; 25: 53-54.

  11. Curry MC, Montgomery H, Winkelmann RK. “Giant basal cell carcinoma”. Arch Dermatol 1977; 113: 316-319.

  12. Horlock N, Wilson GD, Daley FM, Richman PI, Grobbelaar AO, Sanders R, et al. “Cellular proliferation characteristics do not account for the behaviour of horrifying basal cell carcinoma. A comparison of the growth fraction of horrifying and non horrifyingtumours”. Br J PlastSurg. 1998; 51: 59-66.

  13. Beck HI, Andersen JA, Birkler NE, Ottosen PD. “Giant basal cell carcinoma with metastases and secondary amyloidosis: a report of a case”. Acta Derm Venereol 1983; 63: 564-567.

  14. Wendt JR, Houck JP. “A giant basal cell carcinoma with lymph node metastasis: a case report and review of the literature”. Contemp Surg 1988; 32: 33.

  15. Yamamoto S, Johno M, Kayashima K, Matsunaga W, Ono T. “Giant basal cell carcinoma associated with systemic amyloidosis”. J Dermatol 1996; 23: 329-334.

  16. Kikuchi M, Yano K, Kubo T, Hosokawa K, Yamaguchi Y, Itami S. “Giant basal cell carcinoma affecting the lower abdominal, genital and bilateral inguinal regions”. Br J Plast Surg 2002; 55: 445-448.

  17. Piteiro AB, Perez-Espana L, Hervella M, Casado M. “Giant basal cell carcinoma”. J Dermatol. 2003; 30: 573-575.

  18. Arnaiz J, Gallardo E, Piedra T. “Giant basal cell carcinoma on the lower leg: MRI findings”. J Plast Reconstr Aesthet Surg. 2007; 60: 1167-1168.

  19. Mainella M, Majewski WT, Latkovich P, Michaels BM. “Two giant basal cell carcinomas presenting simultaneously in the same patient, one resulting in lower extremity limb loss”. Ann PlastSurg. 1998; 41: 444-447.

  20. Bogdanic B, Smud S, Bagatin D, Nola M, Mijatovic D, Majerovic M. “Giant Basal Cell Carcinoma of the Back: A Case Report and Review of the Literature”, Coll Antropol. 2009; 33(1): 315-318.

  21. Gullet Y, Goldberg N, Silverman R, Gastman B. “What Is the Best Surgical Margin for a Basal Cell Carcinoma: A Meta-Analysis of the Literature”. Plast Reconstr Surg. 2010, 126 (4): 1222-1231.

  22. Neville JA, Welch E, Leffell DJ. “Management of nonmelanoma skin cancer in 2007”. Nature Clin Pract Oncol 2007; 4: 462-469.

  23. Anwar U, Al Ghazal SK, Ahmad M, Sharpe DT. “Horrifying basal cell carcinoma forearm lesion leading to shoulder disarticulation”. Plast Reconstr Surg 2006; 117(1): 6e-9e.

  24. Balaguer-Cambra, Landin Jarillo, Gillen Morales. “Latissimusdorsi volteado para reconstrucción de carcinoma basocelular gigante en un paciente anciano”. Cir. Plast Iberolatinoam 2009; 35(1): 69-72.

  25. Rossi R, Campolmi P, Giomi B, Massi D, Cappugi P. “Giant exophytic basal cell carcinoma treated with radiotherapy”. J Eur Acad Dermatol Venereol 2002; 16: 374-376.

  26. Granados-García M, Vega MT, Tenorio C, Herrera-Gómez A. “Carcinomas de la piel”. En: Granados-García M, Herrera-Gómez A. Manual de oncología, procedimientos médico quirúrgicos, 4ª ed., México, DF: Mc- Graw Hill, 2010, pp. 897-908.

  27. Caloglu M, Yurut-Caloglu V, Kocat Z, Uzal C, “Metastatic giant basal cell carcinoma and radiotherapy”. Br J Plast Recons AesthSurg 2006; 59: 783-784.

  28. Barnes EA, Breen D, Culleton S, et al. “Palliative radiotherapy for non-melanoma skin cancer”. Clin Oncol (R Coll Radiol) 2010; 22: 844-849.

  29. Van Hezewijk M, Creutzberg CL, Putter H, Chin A, Schneider I, Hoogeveen M, et al. “Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases”. Radiother Oncol 2010; 95: 245-249.

  30. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. “Efficacy and safety of vismodegib in advanced basal-cell carcinoma”. N Engl J Med 2012; 366: 2171-2179.




2020     |     www.medigraphic.com